See All Slides - tctmd.com

Slides

Presentation AHA 2014

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

Presenter: C.Kaiser

November 16, 2014

Presentation

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

Presenter: B.P. Bonaca

December 02, 2014

Presentation ICI 2014

The Importance of Brain Protection During Cardiovascular Procedures

Presenter: Alexandra Lansky

December 14, 2014

Presentation

Health Status After TAVR in Patients At Extreme Surgical Risk: Results From the CoreValve US Trial

Presenter: R.L. Osnabrugge

February 16, 2015

Presentation CTO 2015

Pathological Insights into CTO-PCI

Presenter: Jeffrey W. Moses, Gerald S. Werner, Michael Joner

February 26, 2015

Presentation

BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI

Presenter: Yaling Han

March 23, 2015

Presentation

3-Year Outcomes Associated With Embolic Protection in Saphenous Vein Graft Intervention

Presenter: JM Brennan

March 27, 2015

Presentation

Readmissions After Carotid Artery Revascularization in the Medicare Population

Presenter: M.S. Al-Damluji

April 06, 2015

Presentation Intravascular Coronary Imaging and Physiology 2015

How Do I Identify a Culprit Lesion or a Vulnerable Plaque?

Presenter: Ziad A. Ali

April 18, 2015

Presentation ARCH 2015

Pulmonary Valve Disease

Presenter: David Balzer

April 10, 2015

Advertisement

Slides

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

The Importance of Brain Protection During Cardiovascular Procedures

Health Status After TAVR in Patients At Extreme Surgical Risk: Results From the CoreValve US Trial

Pathological Insights into CTO-PCI

BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI

3-Year Outcomes Associated With Embolic Protection in Saphenous Vein Graft Intervention

Readmissions After Carotid Artery Revascularization in the Medicare Population

How Do I Identify a Culprit Lesion or a Vulnerable Plaque?

Pulmonary Valve Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content